id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-N-3335-0001,FDA,FDA-2022-N-3335,Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Prognostic Test for  Assessment of Liver Related Disease Progression,Rule,Final Rule,2023-01-17T05:00:00Z,2023,1,2023-01-17T05:00:00Z,,2023-01-17T13:45:34Z,2023-00480,0,0,09000064855f0e08